Cargando…
Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial
BACKGROUND: Based on promising results from a Phase I study of hepatic arterial infusion chemotherapy using a combination of miriplatin and cisplatin powder (DDP-H) for unresectable hepatocellular carcinoma (UMIN-CTR000003541), a multicenter, open-label, randomized phase II study was conducted to ev...
Autores principales: | Kamimura, Kenya, Suda, Takeshi, Yokoo, Takeshi, Kamimura, Hiroteru, Kanefuji, Tsutomu, Tsuchiya, Atsunori, Takamura, Masaaki, Kawai, Hirokazu, Waguri, Nobuo, Yamagiwa, Satoshi, Terai, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425991/ https://www.ncbi.nlm.nih.gov/pubmed/28490356 http://dx.doi.org/10.1186/s12885-017-3320-7 |
Ejemplares similares
-
Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma
por: Kamimura, Kenya, et al.
Publicado: (2012) -
Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two cases
por: Ogawa, Kohei, et al.
Publicado: (2017) -
Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017) -
Rational arrangement of measuring shear wave speed in the liver
por: Yokoo, Takeshi, et al.
Publicado: (2019) -
Renal Impairment in Chronic Hepatitis B: A Review
por: Kamimura, Hiroteru, et al.
Publicado: (2018)